Skip to content
Screener

Fate Therapeutics FATE Q2 2025 earnings

Reported August 12, 2025 · Before market open

Revenue$1.9MBeat by $758.1K
EPS-$0.29Beat by $0.06
Revenue estimate$1.1M
EPS estimate-$0.35

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.3M
EPS estimate-$0.27

FAQ

When did Fate Therapeutics report Q2 2025 earnings?
Fate Therapeutics (FATE) reported Q2 2025 earnings on August 12, 2025 before market open.
What were Fate Therapeutics's Q2 2025 revenue and EPS?
Fate Therapeutics reported revenue of $1.9M and eps of $-0.29 for Q2 2025.
Did Fate Therapeutics beat estimates in Q2 2025?
Revenue beat the consensus estimate of $1.1M by $758.1K. EPS beat the consensus estimate of $-0.35 by $0.06.
How did Fate Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 71.8% from $6.8M a year earlier and eps grew 12.1% from $-0.33.
Where can I find Fate Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-178947) and the 10-Q periodic report (0000950170-25-107309) directly on SEC EDGAR. The filing index links above go to sec.gov.